Advertisement
U.S. markets closed

United Therapeutics Corporation (UTHR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
229.72-13.55 (-5.57%)
At close: 04:00PM EDT
229.50 -0.22 (-0.10%)
After hours: 06:38PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close243.27
Open243.57
Bid229.28 x 100
Ask229.65 x 200
Day's Range229.14 - 243.57
52 Week Range204.44 - 261.54
Volume1,114,533
Avg. Volume406,550
Market Cap10.81B
Beta (5Y Monthly)0.52
PE Ratio (TTM)11.60
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
-1% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for UTHR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • United Therapeutics Corporation
    Analyst Report: United Therapeutics CorpUnited Therapeutics is a biotechnology company focused on the development and commercialization of therapeutic products for patients with cardiovascular conditions, cancer and infectious diseases. It has five approved products on the market and a strong new product pipeline. The company has roughly 1,168 employees and is a component of the S&P 400.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more